Related Experiment Videos
Recurrent cervical cancer: detection and prognosis
Annette Duyn1, Marion Van Eijkeren, Gemma Kenter
1Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam, The Netherlands.
Acta Obstetricia Et Gynecologica Scandinavica
|August 14, 2002
Summary
Recurrent cervical cancer is rarely detected during routine follow-up (32%). Most recurrences are identified through patient-reported symptoms (87%), highlighting the importance of symptom awareness for early detection and improved survival outcomes.
Area of Science:
- Gynecologic Oncology
- Clinical Cancer Research
- Epidemiology
Background:
- Cervical cancer recurrence detection during routine follow-up is limited.
- Investigating diagnostic tools and prognostic factors for recurrent cervical cancer is crucial.
Purpose of the Study:
- To determine the percentage of cervical cancer recurrences detected during follow-up.
- To identify helpful diagnostic tools for recurrent disease.
- To ascertain prognostic factors for survival in recurrent cervical cancer patients.
Main Methods:
- Retrospective analysis of clinical records from 277 patients treated for cervical cancer (stage IB-IVA).
- Data collected on primary tumor characteristics, recurrent disease, and follow-up protocols.
- Patients achieved at least 3 months of complete remission post-primary treatment.
Main Results:
- 17% (47/277) of patients developed recurrent disease.
- Recurrence detection: 45% via self-referral, 32% during routine follow-up.
- Symptoms (87%) were the primary indicator for recurrence diagnosis; disease-free interval (DFI) was a significant prognostic factor.
Conclusions:
- Routine follow-up detects only 32% of cervical cancer recurrences.
- Symptom presentation (87%) is the predominant method for detecting recurrent disease.
- Disease-free interval (DFI) is a key prognostic factor for survival in recurrent cervical cancer.